ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

2LB Iovance Biotherapeutics Inc

8.172
0.00 (0.00%)
10:02:10 - Realtime Data

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000001.19M
Operating Income -53.64M-92.88M-128.26M-206.87M-261.94M-342.7M-398.88M-460.56M
Pre Tax Income -52.89M-92.06M-123.58M-197.56M-259.58M-342.25M-395.89M-447.52M
Net Income -102.35M-92.06M-123.58M-197.56M-259.58M-342.25M-395.89M-444.04M
Preferred Dividends -49.45M0000000
Basic Earnings Per Share (EPS) -1.644-1.258-1.001-1.517-1.723-2.141-2.076-1.716
EBIT -53.64M-92.88M-128.26M-206.87M-261.94M-342.7M-398.88M-460.56M
EBITDA -52.66M-91.93M-127.3M-205.7M-260.8M-339.59M-389.57M-439.14M